BioCentury
ARTICLE | Company News

Kyto Biopharma Inc. deal

December 3, 2007 8:00 AM UTC

Undisclosed companies will manufacture murine antibodies for Kyto. Kyto will use the antibodies to develop humanized MAbs targeting vitamin B12 receptor to treat cancer. Financial terms were not disc...